Innate lymphoid cells (ILCs) 'preferentially' localize into barrier tissues, where they function in tissue protection but can also contribute to inflammatory diseases. The mechanisms that regulate the establishment of ILCs in barrier tissues are poorly understood. Here we found that under steady-state conditions, ILCs in skin-draining lymph nodes (sLNs) were continuously activated to acquire regulatory properties and high expression of the chemokine receptor CCR10 for localization into the skin. CCR10 + ILCs promoted the homeostasis of skin-resident T cells and, reciprocally, their establishment in the skin required T cell-regulated homeostatic environments. CD207 + dendritic cells expressing the transcription factor Foxn1 were required for the proper generation of CCR10 + ILCs. These observations reveal mechanisms that underlie the specific programming and priming of skin-homing CCR10 + ILCs in the sLNs.
Innate lymphoid cells (ILCs) are innate lymphocytes that undergo 'preferential' enrichment in barrier tissues such as the intestine, lung and skin, where they have important roles in establishing the local tissue homeostasis [1] [2] [3] [4] . Although ILCs do not express lineagespecific cell-surface markers, they express the hematopoietic lineage marker CD45 and surface molecules commonly associated with lymphocytes, such as CD90 and CD127 (ref. 1). On the basis of their functional potential and developmental requirements, and by analogy to helper T cell subsets, ILCs are commonly divided into three groups (ILC1-ILC3) 1 . The ILC1 group comprises natural killer cells and other ILCs that, when activated, produce mainly cytokines characteristic of the T H 1 subset of helper T cells, such as interferon γ (IFN-γ); ILC2 cells produce T H 2-type cytokines such as interleukin 5 (IL-5) and IL-13; and ILC3 cells produce T H 17-type cytokines such as IL-17 and IL-22. Through the production of unique cytokines and direct cell-cell interaction, distinct ILC subsets interact with various other cells of the immune system, such as T cells, mast cells, eosinophils and dendritic cells (DCs), to maintain homeostasis in local tissues [4] [5] [6] [7] .
Dysregulated activated ILCs are also involved in tissue inflammatory diseases. IL-23-and IL-1β-responsive ILC3-like cells might contribute to intestinal inflammatory diseases [8] [9] [10] . IL-13-producing ILC2 cells are suggested to have a role in various types of lung inflammation [11] [12] [13] [14] . ILC2 cells mediate skin inflammation in mouse models of atopic dermatitis 4, [15] [16] [17] , while IL-17-producing ILC3 cells are reported to contribute to Aldara (imiquimod) cream-induced psoriatic disease development in mice 18 . It has been suggested that pathogenic ILCs might be different from ILCs involved in tissue homeostatic regulation in terms of their surface receptor expression and regulation of activation. For example, among IL-17-producing ILCs, the subset expressing the IL-23 receptor (IL-23R) is pathogenic, while the IL-23R − subset is not 9 . However, how they are generated differentially is not clear.
Despite the diverse roles of ILCs in both homeostasis and inflammation in different barrier tissues, the mechanisms that regulate their tissue-specific localization and functions are poorly understood. It has been suggested that ILCs acquire specific homing properties for their 'preferential' localization into barrier tissues during their development in the bone marrow (BM), while their activation happens in situ in the periphery 19, 20 . Most circulating ILC2 cells are found in an inactivated state and express the common epithelial tissue-homing molecule and chemokine receptor CCR6, which might direct their 'preferential' migration into various epithelial tissues 19, 20 . It has also been reported that most developing precursors of ILC2 cells in BM and ILC2 cells in the intestine express CCR9, a homing molecule and chemokine receptor important for their proper localization in the intestinal lamina propria 21 . However, ILCs, including ILC2 cells, are abundant in other barrier tissues, such as the skin. ILCs isolated from the skin of healthy people express CCR10 (ref. 16 ), a homing molecule and chemokine receptor involved in the localization of T cells into the homeostatic skin through interaction with CCL27, a skin-specific ligand of CCR10 expressed by keratinocytes 22, 23 . Given the complexity of the requirements for the migration of lymphocytes in different barrier tissues under homeostatic and inflammatory conditions, additional layers of regulation are probably required for the specific localization and functions of ILCs. Here we report that ILCs were programmed in skin-draining lymph nodes (sLNs) to acquire skin-homing properties for the homeostatic establishment of skin ILC pool. In addition, under homeostatic or inflammatory conditions, sLNs programmed the generation of activated ILCs with distinct properties to help regulate the local homeostasis and inflammation.
RESULTS

Generation of skin-specific CCR10 + ILCs in sLNs
We used Ccr10 +/EGFP reporter mice, which express one wild-type Ccr10 allele and sequence encoding enhanced green fluorescent protein (EGFP) knocked into the other Ccr10 allele 23, 24 , to study ILCs in the sLNs. The majority of CD45 + CD3 − Lin − cells in the skin and sLNs of Ccr10 +/EGFP mice were CD127 + CD90 + EGFP + (CCR10 + ) ILCs, while CD45 + CD3 − Lin − cells in the intestine and lung mucosa, intestine-draining mesenteric lymph nodes (mLNs), BM and spleen were CCR10 − (Fig. 1a,b) . Nearly all CCR10 + skin ILCs and most CCR10 + sLN ILCs expressed other common epithelial tissue-homing and adhesion molecules, such as CCR6, CD103 and CD69 (Fig. 1c) . CCR10 + ILCs of the skin and sLNs expressed the lymphocyteactivation marker CD44, and significantly greater frequency of them were Ki67 + than were the corresponding CCR10 − ILCs (Fig. 1d) , which suggested that the CCR10 + ILCs were more activated. A greater frequency of CCR10 + skin and sLN ILCs than the corresponding A r t i c l e s npg A r t i c l e s mice into wild-type (CD45.1 + CD45.2 + ) mice. At 2 d after the cell transfer, about 80% of donor ILCs in the skin of recipient mice were CCR10 + MHCII + ( Fig. 2a) , which suggested that the injected CCR10 + MHCII + sLN ILCs migrated rapidly into the skin. In confirmation of that conclusion, sorter-purified CCR10 + sLN ILCs were present in the skin of wild-type recipient mice 2 d after transfer, but CCR10 − sLN ILCs were not (Fig. 2b) , and the CCR10 + ILCs were maintained in the skin 2 weeks after transfer ( Fig. 2c) . In addition, most CCR10 + MHCII + donor ILCs in the skin of recipient mice became CCR10 + MHCII − 2 weeks after transfer ( Fig. 2c) , which indicated downregulation of MHC class II expression. No CCR10 + donor ILCs could be found in sLNs 2 d or 2 weeks after transfer (Fig. 2b,c) , which suggested that the CCR10 + ILCs did not recirculate back to sLNs once they had localized into the skin. Thus, adoptively transferred CCR10 + MHCII + sLN ILCs were able to migrate to the skin, where they were also able to become CCR10 + MHCII − ILCs.
To determine whether continuous input of CCR10 + MHCII + ILCs from sLNs was required for the homeostatic establishment of ILCs in the skin, we provided FTY720 to Ccr10 +/EGFP mice in their drinking water; this drug sequesters lymphocytes in LNs 26 . Mice thus treated with FTY720 had significantly more CCR10 + ILCs in sLNs and significantly fewer CCR10 + ILCs, especially CCR10 + MHCII + ILCs, in the skin than did untreated mice ( Fig. 2d and Supplementary  Fig. 2a ). Treatment with FTY720 also caused the accumulation of CCR10 + T cells in sLNs and a reduction in the abundance of these CCR10 − ILCs were IL-17 + (ILC3) or IL-5 + (ILC2), but few CCR10 + skin and sLN ILCs produced IFN-γ or IL-10 ( Fig. 1e ). Most CCR10 + skin and sLN ILCs expressed the transcription factor GATA-3 but did not express the transcription factor T-bet ( Supplementary Fig. 1a ), consistent with their expression of IL-5 but no IFN-γ. CCR10 + skin and sLN ILCs did not express the transcription factor RORγt 25 (Supplementary Fig. 1b ), even though a significant portion of them expressed IL-17 ( Fig. 1e) .
A fraction of intestinal ILC3 cells are reported to have high expression of major histocompatibility complex (MHC) class II and to have regulatory antigen-presenting cell (APC) abilities 5 . Notably, most CCR10 + skin and sLN ILCs had high expression of MHC class II, while CCR10 − ILCs had little or no expression of MHC class II ( Fig. 1f and Supplementary Fig. 1c ), regardless of their expression of IL-5 and IL-17 ( Supplementary Fig. 1d ). In addition, most CCR10 + skin and sLN ILCs expressed the co-inhibitory molecule PD-L1, while they had no or low expression of other co-stimulatory or co-inhibitory molecules, such as CD80, CD86, PD-L2, B7x, B7h, B7H3, OX40L and CD40 ( Supplementary Fig. 1e,f ). Together these results suggested that the CCR10 + ILCs were skin-specific ILCs with regulatory APC potential that were generated in sLNs under homeostatic conditions.
Predominant migration of sLN CCR10 + MHCII + ILCs into the skin
To determine whether the CCR10 + sLN ILCs migrated into the skin, we intravenously injected total sLN cells from Ccr10 +/EGFP (CD45.2 + ) 
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A r t i c l e s cells in the skin (Supplementary Fig. 2b) . These results demonstrated that the homeostatic presence of ILCs in the skin required continuous input of CCR10 + MHCII + ILCs from sLNs. sLNs are essential for the homeostasis of skin CCR10 + ILCs Published studies have found abundant ILCs in the skin of LNdeficient RORγt-deficient (Rorc −/− ) mice 16, 27 . However, there were essentially no CCR10 + MHCII + skin ILCs in Rorc −/− Ccr10 +/EGFP mice ( Fig. 2e and Supplementary Fig. 2c ), which suggested that sLNs were critical for the homeostatic establishment of CCR10 + ILCs in the skin. There was also a lower frequency of CCR10 + T cells in the skin of Rorc −/− Ccr10 +/EGFP mice than in that of Ccr10 +/EGFP mice (Supplementary Fig. 2d) , consistent with the hypothesis that CCR10 + T cells are programmed in sLNs 28 . The frequency of IL-17 + skin ILCs was also lower in Rorc −/− Ccr10 +/EGFP mice than in Ccr10 +/EGFP mice (Supplementary Fig. 2e ). Similar to RORγt, the transcription factor Ahr is important for the development of IL-17 + ILC3 cells in intestines 29 , but Ahr −/− Ccr10 +/EGFP mice had normal LN development, and they had apparently normal generation and establishment of sLN and skin ILCs and CCR10 + skin T cells ( Fig. 2e and Supplementary Fig. 2f-i) .
We reconstituted irradiated wild-type mice with total Rorc −/− Ccr10 +/EGFP BM cells and reconstituted irradiated Rorc −/− mice with total Ccr10 +/EGFP BM cells. Donor Rorc −/− Ccr10 +/EGFP BM cells gave rise to abundant MHCII + CCR10 + skin ILCs in the wild-type recipient mice, while donor Ccr10 +/EGFP BM cells did not efficiently give rise to CCR10 + skin ILCs, particularly MHCII + CCR10 + skin ILCs, in Rorc −/− recipient mice (Fig. 2f) . This indicated that altered host environments, most probably a lack of sLNs, were responsible for the impaired establishment of CCR10 + ILCs in the skin of Rorc −/− Ccr10 +/EGFP mice.
We then treated Ccr10 +/EGFP mice in utero with fusions of the lymphotoxin-β receptor and immunoglobulin (LTβR-Ig) to selectively block their LN development 30 . When analyzed 1.5-2 months after birth, the LTβR-Ig-treated mice had a significantly lower frequency of CCR10 + skin ILCs, particularly MHCII + CCR10 + skin ILCs, than did their untreated counterparts ( Fig. 2g and Supplementary  Fig. 2j ). Together these results demonstrated that sLNs were critically required for programming CCR10 + ILCs for the homeostatic establishment of the skin ILC pool.
CCR10 and CCR6 co-regulate the localization of ILCs in the skin
To determine the role of CCR10 in the migration and establishment of CCR10 + ILCs into the skin, we compared the abundance of EGFP + ILCs in the sLNs, skin and spleen of Ccr10 EGFP/EGFP mice, which do not express CCR10 protein 24 , and their Ccr10 +/EGFP littermates. Ccr10 EGFP/EGFP mice had a frequency and number of EGFP + MHCII + ILCs in sLNs similar to if not greater than that of their Ccr10 +/EGFP littermates ( Fig. 3a and Supplementary Fig. 3a) . In contrast, there was a lower frequency of EGFP + MHCII + ILCs in the skin of Ccr10 EGFP/EGFP mice than in that of Ccr10 +/EGFP mice, while the frequency of EGFP + MHCII − or EGFP − MHCII − ILCs in Ccr10 EGFP/EGFP mice was greater than or not significantly different from that in their Ccr6 npg A r t i c l e s Ccr10 +/EGFP counterparts ( Fig. 3a and Supplementary Fig. 3a,b) . Given our finding that the EGFP + MHCII + ILCs in the skin were 'newcomers' emigrating from sLNs ( Fig. 2a-c) , these results suggested that CCR10 was required for their localization into the skin but that increased maintenance of other subsets of ILCs might compensate for the absence of CCR10 expression on EGFP + MHCII + ILCs. There was a significantly greater frequency of EGFP + ILCs in the spleen of Ccr10 EGFP/EGFP mice than in that of Ccr10 +/EGFP mice (Fig. 3a) , which suggested that CCR10-deficient EGFP + ILCs abnormally accumulated in lymphoid organs that do not express CCR10 ligands. CCR10 deficiency did not affect expression of other homing or activation molecules or cytokine production by skin or sLNs EGFP + ILCs (Supplementary Fig. 3c) .
To assess the intrinsic requirement for CCR10 expression in the establishment of ILCs in the skin, we transferred similar numbers of Ccr10 +/EGFP total BM cells and Ccr10 EGFP/EGFP total BM cells together into irradiated wild-type mice. At 2 months after transfer, Ccr10 +/EGFP donor cells contributed significantly more to EGFP + and EGFP − skin ILCs than did Ccr10 EGFP/EGFP donor cells (Fig. 3b,c) , which indicated that the impaired localization of Ccr10 EGFP/EGFP EGFP + sLN ILCs into the skin affected both EGFP + skin ILCs and EGFP − skin ILCs. There was also a lower abundance of donor Ccr10 EGFP/EGFP EGFP + ILCs in the sLNs of the recipient mice (Fig. 3b,c) , which suggested that CCR10 deficiency impaired the proper maintenance of CCR10 + ILCs in sLNs, an effect that might have been homeostatically compensated at steady state in Ccr10 EGFP/EGFP mice. Ccr10 EGFP/EGFP donor cells contributed more than Ccr10 +/EGFP donor cells to the EGFP + ILC population in the spleen of host mice (Fig. 3b,c) , consistent with the abnormal accumulation of EGFP + ILCs in the spleen of Ccr10 EGFP/EGFP mice (Fig. 3a) . In addition, Ccr10 EGFP/EGFP EGFP + sLN ILCs migrated much less efficiently into the skin than did Ccr10 +/EGFP EGFP + sLN ILCs when transferred together into the same wild-type host mouse ( Fig. 3d and  Supplementary Fig. 3d) . These results demonstrated that CCR10 was important for the migration of CCR10 + MHCII + sLN ILCs into the skin for the homeostatic establishment of skin ILCs.
CCR6 was expressed on most sLN and skin CCR10 + or CCR10 − ILCs (Fig. 1c) . Ccr6 −/− mice had a frequency of CCR10 + MHCII + ILCs similar to that of their CCR6-sufficient littermates (Fig. 3a) but had fewer total CCR10 + ILCs in the skin than did their CCR6-sufficient littermates, largely due to a lower frequency of of total ILCs in the CD45 + population (Supplementary Fig. 3a,b) . However, Ccr6 −/− mice did not show more accumulation of CCR10 + ILCs in spleens than that of their CCR6-sufficient littermates (Fig. 3a) . Compared with the abundance of such cells in Ccr10 +/EGFP mice versus Ccr10 EGFP/EGFP mice, Ccr10 EGFP/EGFP Ccr6 −/− mice had even fewer EGFP + MHCII + ILCs in the skin and more EGFP + ILCs in spleens than Ccr10 EGFP/EGFP mice ( Fig. 3a and Supplementary Fig. 3a) . Thus, CCR6 and CCR10 coordinately regulated the localization and maintenance of CCR10 + and CCR10 − ILCs in the skin.
T cells and immunological homeostasis help program CCR10 + ILCs
Because in addition to controlling ILC localization, CCR10 also controls T cell localization in the skin 23 , we investigated the presence of CCR10 + skin and sLN ILCs in the absence of T cells in Ccr10 +/EGFP mice lacking expression of the gene encoding the recombinase component RAG-1 (and thus lacking mature T cells and B cells) (Rag1 −/− Ccr10 +/EGFP mice). Few skin ILCs in Rag1 −/− Ccr10 +/EGFP mice expressed CCR10 or MHCII, while they still had high expression of CCR6, CD103 and CD44 ( Fig. 4a and Supplementary Fig. 4a,b) . The expression of IL-17 and IL-5 was also similar in CCR10 − Rag1 −/− Ccr10 +/EGFP skin ILCs and CCR10 + Ccr10 +/EGFP skin ILCs (Supplementary Fig. 4c ). There was still a high frequency of CCR10 + MHCII + ILCs in the sLNs of Rag1 −/− Ccr10 +/EGFP mice (Fig. 4b) .
However, CCR10 − sLN ILC populations in Rag1 −/− Ccr10 +/EGFP mice were also activated, as they had higher expression of CD44, CCR6 and CD103 and included more proliferative Ki-67 + cells than did npg A r t i c l e s their CCR10 − counterparts in Ccr10 +/EGFP mice (Fig. 4c,d and Supplementary Fig. 4b) . At 2 d after intravenous injection of total Rag1 −/− Ccr10 +/EGFP sLN ILCs into Rag1 −/− recipient mice, both CCR10 + donor ILCs and CCR10 − donor ILCs were present in the skin (Supplementary Fig. 4d ), which suggested that both CCR10 + sLN ILCs and CCR10 − sLN ILCs were able to migrate into the recipient skin. Most donor ILCs in the skin of Rag1 −/− recipient mice were MHCII − (Supplementary Fig. 4d) , which suggesting downregulation of MHC class II. In support of that conclusion, purified Rag1 −/− Ccr10 +/EGFP or Ccr10 +/EGFP CCR10 + MHCII + sLN ILCs all became CCR10 − MHCII − by 4 weeks after transfer into Rag1 −/− recipient mice (Supplementary Fig. 4d) . These results suggested that T cells and B cells were important for the proper programming of ILCs in sLNs and the homeostatic presence of CCR10 + ILCs in the skin. We then injected wild-type splenic CD4 + T cells intravenously into Rag1 −/− Ccr10 +/EGFP recipient mice. The T cell reconstitution increased the frequency of CCR10 + ILCs and CCR10 + MHCII + ILCs in the skin twofold and fourfold, respectively, compared with that of unreconstituted Rag1 −/− Ccr10 +/EGFP mice (Fig. 4e) , but had no or small effect on the activation of CCR10 − and CCR10 + ILCs in the sLNs of recipients (Supplementary Fig. 4e ). This suggested that the CD4 + T cells helped in the maintenance of CCR10 + ILCs in the skin. We also depleted wild-type splenic CD4 + T cell samples of regulatory T cells (T reg cells) and injected the T reg cell-depleted T cell samples or T reg cells separately into Rag1 −/− Ccr10 +/EGFP recipients. Neither transfer increased the frequency of CCR10 + skin ILCs in the Rag1 −/− Ccr10 +/EGFP recipients (Fig. 4e) . Therefore, both effector T cells and T reg cells were required for the homeostatic presence of CCR10 + ILCs in the skin.
We additionally analyzed sLN and skin ILCs in Foxp3 −/− Ccr10 +/EGFP mice, which lack all T reg cells and develop severe organ inflammation. Foxp3 −/− Ccr10 +/EGFP mice had a much lower frequency and number of CCR10 + ILCs in the skin as well as sLNs than that of Ccr10 +/EGFP mice (Fig. 4f,g and Supplementary Fig. 4f ), which suggested that inflammation might affect the generation of CCR10 + ILCs in sLNs and their presence in the skin. Consistent with that, topical treatment of Ccr10 +/EGFP mice with calcipotriol, which induces atopic dermatitis-like skin inflammation [15] [16] [17] , resulted in a reduction in CCR10 + ILCs in the sLNs and skin of twofold and 1.5-fold, respectively, compared with that of untreated mice ( Fig. 4h and Supplementary Fig. 4g) . Therefore, the generation and presence of CCR10 + ILCs in sLNs and the skin depended on local immunological homeostasis.
Skin ILCs promote homeostasis of resident T cells in the skin
We next transferred splenic CD4 + T cells from Ccr10 +/EGFP mice into Ccr10 EGFP/EGFP Rag1 −/− recipient mice to determine whether skin CCR10 + ILCs were needed to help the homeostasis of skin T cells. Ccr10 EGFP/EGFP Rag1 −/− recipient mice had a significantly lower frequency of T reg cells among total donor cells in the skin than did Rag1 −/− recipient mice (Fig. 5a) . The frequency of donor CD4 + T cells that produced IL-17, IFN-γ and IL-5 was similar in Ccr10 EGFP/EGFP Rag1 −/− recipient mice and Rag1 −/− recipient mice (Supplementary Fig. 5a ). Therefore, CCR10 + ILCs were particularly important in supporting the presence of T reg cells in the skin.
We also transferred CD4 + splenic T cells into Il2rg −/− Rag2 −/− host mice, which lack all ILCs 3,31,32 . The frequency of T reg cells among total donor cells was two-to threefold lower in the skin of Il2rg −/− Rag2 −/− recipient mice than in that of Rag1 −/− recipient mice (Fig. 5b) .
In addition, nearly all donor CD4 + T cells in the skin of Il2rg −/− Rag2 −/− recipient mice were CCR10 − (Fig. 5b) and had significantly higher expression of IL-17 and IL-5, but much lower expression of IFN-γ, than that of T cells in Rag1 −/− recipient mice (Fig. 5c,d) . These results suggested that skin ILCs regulated the homeostasis of skin T cells.
Programming of CCR10 + ILCs requires Foxn1 and CD207 + DCs
We next investigated the mechanisms underlying the specific programming of CCR10 + ILCs in sLNs. Foxn1 is a transcription factor selectively expressed in thymic and skin epithelial cells, such as keratinocytes 33, 34 . Like Rag1 −/− Ccr10 +/EGFP mice, Foxn1 −/− Ccr10 +/EGFP mice, which have impaired T cell and skin development, had a substantially lower frequency of CCR10 + ILCs, particularly CCR10 + MHCII + skin ILCs, than did their Ccr10 +/EGFP littermates ( Fig. 6a and Supplementary  Fig. 6a) . Additionally, Foxn1 −/− mice had a significantly lower frequency of CCR10 + ILCs in sLNs than did Rag1 −/− mice (Fig. 6a) , npg A r t i c l e s which suggested that Foxn1 was involved in regulating molecules or cells important for the generation of sLN CCR10 + ILCs. We transferred total Ccr10 +/EGFP BM cells into irradiated Foxn1 −/− host mice. We found a significantly lower frequency of Ccr10 +/EGFP donor CCR10 + and CCR10 + MHCII + ILCs in the sLNs (Fig. 6b ) and skin ( Supplementary Fig. 6b ) of Foxn1 −/− recipient mice than in that of wild-type recipient mice. This suggested that the Foxn1 expressed in 'radio-resistant' cells, such as keratinocytes and epidermal DCs, was important for the generation and establishment of CCR10 + MHCII + ILCs in sLNs and the skin.
To identify the Foxn1 + cells important for the generation and maintenance of CCR10 + ILCs in sLNs and skin, we first used the Foxn1 +/Cre Gt(ROSA)26Sor +/RFP reporter mice to assess the currently or previously Foxn1-expressing cells. In these mice, Foxn1 had selective and high expression in a large fraction of CD207 + (langerinpositive) CD45 + CD3 − CD11c + DCs of the skin and sLNs, while DCs from the intestine and mLNs did not express Foxn1 (Fig. 6c) . Both CD103 − CD207 + DCs (of epidermal origin) and CD103 + CD207 + DCs (of dermal origin) expressed Foxn1 (Supplementary Fig. 6c ).
We next studied MuLanDTR mice, which have transgenic expression of the receptor for diphtheria toxin (DTR) in all CD207 + DCs 35 ; we temporarily depleted these mice of CD207 + DCs via injection of diphtheria toxin (DT). MuLanDTR mice treated with DT for 8 d had a lower frequency of CCR10 + MHCII + ILCs in sLNs, but not in the skin, than that of untreated MuLanDTR mice ( Fig. 6d  and Supplementary Fig. 6d) , whereas the frequency of CCR10 + T cells in sLNs was unchanged (Supplementary Fig. 6e) . A longer period of DT treatment (17-21 d) reduced the frequency of CCR10 + MHCII + ILCs in the sLNs and skin compared with that of untreated mice ( Fig. 6d) and also slightly reduced the frequency of CCR10 + T cells in sLNs and the skin (Supplementary Fig. 6e ). We then specifically depleted HuLanDTR mice 36 of epidermal CD207 + DCs via injection of DT. DT-treated HuLanDTR mice had a lower frequency of CCR10 + MHCII + ILCs in sLNs and the skin than did untreated HuLanDTR mice (Fig. 6e) , although the reduction was smaller than that observed for DT-treated MuLanDTR mice. DT treatment did not significantly reduce the frequency of sLN or skin CCR10 + T cells in HuLanDTR mice (P > 0.05; Supplementary  Fig. 6f ). Thus, both epidermal CD207 + DCs and dermal CD207 + DCs were involved in the generation and maintenance of CCR10 + ILCs in sLNs and the skin.
DISCUSSION
Our studies here have revealed that like helper T cells, ILCs were programmed in sLNs with specific homing and functional abilities for localization and function in the skin. In the skin, CCR10 + ILCs promoted the homeostasis of T reg cells and effector T cells. Reciprocally, T cells, including T reg cells, were required for homeostatic presence of skin CCR10 + ILCs. These results suggest functional crosstalk between CCR10 + ILCs and T cells in the skin for their tissue maintenance and function.
ILCs originate in the BM. Our findings revealed that after leaving BM, ILCs were still able to undergo further differentiation. Such an ability to continue differentiating might be important in allowing A r t i c l e s the cells to enter different peripheral tissues in response to different stimulations under homeostatic and inflammatory conditions. Under homeostatic conditions, CCR10 + ILCs generated in sLNs, which have high expression of MHC class II and the inhibitory mediator PD-L1, are probably involved in the homeostatic regulation of helper T cells, including T reg cells, after migrating into the skin. However, whether ILCs directly regulate the homeostatic regulation of helper T cells is still yet to be determined. ILCs probably also modulate the homeostasis of mast cells or other cells of the immune system in the skin 4 . Reciprocally, maintenance of CCR10 + ILCs in the skin was dependent on other resident cells of the immune system, including CD4 + T cells. How CCR10 + ILCs, CD4 + T cells and other cells of the immune system engage in cross-talk to regulate skin immunological homeostasis and responses under various stimulatory conditions is an important question for future study. In one of our preliminary studies, Il2rg −/− Rag2 −/− mice reconstituted with CD4 + T cells had less innate skin inflammation in response to topical application of the irritant DNFB (2,4-dinitro-1-fluorobenzene) than that of Rag1 −/− or Ccr10 EGFP/EGFP Rag1 −/− mice reconstituted in the same way (data not shown), which suggested that ILCs might have an important role in driving early immune response to stimulations on the skin. Future studies should test whether ILCs are involved in the regulation of adaptive T cells response to DNFB re-challenge. ILC2 cells and ILC3 cells are reported to contribute to the skin inflammation 4, [15] [16] [17] [18] . In the various mouse models of skin inflammation and homeostatic dysregulation we tested, we noticed a reduction in CCR10 + ILCs and an increase in CCR10 − ILCs in the sLNs and skin. Given such a shift, it is possible that the pathogenic ILCs that mediate skin inflammation might be different from homeostatic ILCs. However, CCR10 − ILCs in inflamed skin and sLNs had the same ability to produce IL-17 and IL-5 as that of CCR10 + ILCs in homeostatic skin, which suggested that cellular properties other than cytokine production potential might be involved in their function as regulatory ILCs versus inflammatory ILCs.
The transcription factor Foxn1, which is selectively expressed in skin epithelial cells and skin and sLN-specific CD207 + DCs, but not in epithelial cells or DCs of other mucosal tissues, was at least partially responsible for the specific programming of CCR10 + ILCs in sLNs. Potentially, Fonx1 might regulate the expression of soluble factors and membrane ligands in both skin epithelial cells and CD207 + DCs for the proper programming of CCR10 + ILCs. Paralleling that proposal, skin epithelial cells and skin-derived DCs have both been linked to the programming of skin-homing T cells 28, 37, 38 . However, the molecular events and cellular interactions involved in the specific programming of skin-homing CCR10 + ILCs need further investigation.
Together with the finding that CCR10 expressed on skin-resident T cells is important in the homeostatic maintenance and prevention of over-activation of T cell responses to skin stimulation 23 , our observation that CCR10 + ILCs were also involved regulating skin immunological homeostasis fully establishes CCR10 as a regulator of immunological homeostasis in the skin. Published studies have found that CCL27 expression is upregulated in the inflamed skin of humans with psoriasis and atopic dermatitis 39, 40 but is downregulated in severe skin lesions of psoriasis 41, 42 , which suggests that a lack of the CCR10-ligand signaling is associated with severe psoriatic inflammation. In addition, it has been reported that the vast majority of ILCs in the healthy skin of humans express CCR10 (ref. 16 ). Future studies should determine whether a severe psoriatic skin lesion is associated with a decrease in the abundance of CCR10 + ILCs. Given the role of CCR10 in skin immunoregulation, enhancing, rather than inhibiting, CCR10-ligand signaling should represent a useful therapeutic strategy in the restoration of the immunological homeostatic status in the treatment of skin inflammatory diseases such as psoriasis.
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